About the Company
We do not have any company description for iRhythm Technologies, Inc. at the moment.
Sector
Industrial Applications and Services
Industry
Surgical & Medical Instruments & Apparatus
Employees
1344
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on iRhythm Technologies, Inc.
Investor Short Report Flags Steep Downside Risk For iRhythm Technologies
Spruce Point Capital warned iRhythm Technologies could face a 40%–70% stock decline, citing regulatory risks and product ...
AVALON Real-World Evidence Builds on CAMELOT Study Reinforcing iRhythm’s Zio LTCM Clinical Superiority
In the largest real-world study of its kind with 428,707 patients, the Zio LTCM service outperformed other studied monitoring approaches in cardiac arrhythmia diagnostic yield, time to diagnosis, ...
Stewart Denies iRhythm’s Bid to Review Decision Scrapping IPRs Based on ‘Settled Expectations’
In the latest development on USPTO Director Coke Morgan Stewart’s “settled expectations” doctrine, Stewart today denied ...
FDA Clearance Boosts iRhythm Zio Device Innovation and Fuels Growth Potential
Rhythm Technologies, Inc. (NASDAQ:IRTC) is one of the 10 Stocks with Huge Catalysts on the Horizon. The FDA clearance for the Zio AT device upgrades signals the potential for further innovation and ...
iRhythm Fails to Halt Information Exchange in Investor Lawsuit
Rhythm Technologies Inc. investors can proceed with the exchange of documents and other material in their proposed class ...
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by Wells Fargo ...
The company has a current ratio of 6.27, a quick ratio of 6.12 and a debt-to-equity ratio of 9.00. iRhythm Technologies, Inc. has a 1 year low of $55.92 and a 1 year high of $128.52.
iRhythm Technologies, Inc. (IRTC) Q4 2023 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2023 Earnings Conference Call February 22, 2024 4:30 PM ETCompany ParticipantsStephanie Zhadkevich - Director, ...
iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript
iRhythm Technologies, Inc. (NASDAQ: IRTC) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford ...
iRhythm Technologies, Inc. (NASDAQ:IRTC) Shares Sold by State of New ...
State of New Jersey Common Pension Fund D cut its holdings in iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 2.1% during the 4th quarter, Holdings Channel reports. The firm owned ...
Breaking Down iRhythm Technologies: 4 Analysts Share Their Views
In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' t ...
iRhythm Technologies Announces Chief Commercial Officer ... - Nasdaq
--iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that Dave Vort, the Company’ s Chief Commercial Officer ...
Is iRhythm Technologies, Inc. (IRTC) A Good Stock To Buy?
Is IRTC a good stock to buy? iRhythm Technologies, Inc. (NASDAQ: IRTC) was in 22 hedge funds’ portfolios at the end of the second quarter of 2021. The all time high for this statistic is 26.
Similar Companies
Loading the latest forecasts...